Literature DB >> 17522229

The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells.

Asako Murayama1, Tomoko Date, Kenichi Morikawa, Daisuke Akazawa, Michiko Miyamoto, Minako Kaga, Koji Ishii, Tetsuro Suzuki, Takanobu Kato, Masashi Mizokami, Takaji Wakita.   

Abstract

The JFH-1 strain of hepatitis C virus (HCV) is a genotype 2a strain that can replicate autonomously in Huh7 cells. The J6 strain is also a genotype 2a strain, but its full genomic RNA does not replicate in Huh7 cells. However, chimeric J6/JFH-1 RNA that has J6 structural-protein-coding regions and JFH-1 nonstructural-protein-coding regions can replicate autonomously and produce infectious HCV particles. In order to determine the mechanisms underlying JFH-1 RNA replication, we constructed various J6/JFH-1 chimeras and tested their RNA replication and virus particle production abilities in Huh7 cells. Via subgenomic-RNA-replication assays, we found that both the JFH-1 NS5B-to-3'X (N5BX) and the NS3 helicase (N3H) regions are important for the replication of the J6CF replicon. We applied these results to full-length genomic RNA replication and analyzed replication using Northern blotting. We found that a chimeric J6 clone with JFH-1 N3H and N5BX could replicate autonomously but that a chimeric J6 clone with only JFH-1 N5BX had no replication ability. Finally, we tested the virus production abilities of these clones and found that a chimeric J6 clone with JFH-1 N3H and N5BX could produce infectious HCV particles. In conclusion, the JFH-1 NS3 helicase and NS5B-to-3'X regions are important for efficient replication and virus particle formation of HCV genotype 2a strains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522229      PMCID: PMC1951293          DOI: 10.1128/JVI.02088-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  An infectious molecular clone of a Japanese genotype 1b hepatitis C virus.

Authors:  M R Beard; G Abell; M Honda; A Carroll; M Gartland; B Clarke; K Suzuki; R Lanford; D V Sangar; S M Lemon
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

2.  Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA.

Authors:  R Banerjee; A Dasgupta
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

Authors:  Michiko Miyamoto; Takanobu Kato; Tomoko Date; Masashi Mizokami; Takaji Wakita
Journal:  Intervirology       Date:  2006       Impact factor: 1.763

4.  Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient.

Authors:  T Kato; A Furusaka; M Miyamoto; T Date; K Yasui; J Hiramoto; K Nagayama; T Tanaka; T Wakita
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

5.  Hepatitis C virus core protein binds to a C-terminal region of NS5B RNA polymerase.

Authors:  Masao Uchida; Nobumasa Hino; Takayuki Yamanaka; Hitomi Fukushima; Takeshi Imanishi; Yasutoshi Uchiyama; Tatsuhiko Kodama; Takefumi Doi
Journal:  Hepatol Res       Date:  2002-04       Impact factor: 4.288

6.  Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

7.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

9.  Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.

Authors:  Tetsuro Shimakami; Makoto Hijikata; Hong Luo; Yuan Yuan Ma; Shuichi Kaneko; Kunitada Shimotohno; Seishi Murakami
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.

Authors:  Itsuki Hamamoto; Yorihiro Nishimura; Toru Okamoto; Hideki Aizaki; Minyi Liu; Yoshio Mori; Takayuki Abe; Tetsuro Suzuki; Michael M C Lai; Tatsuo Miyamura; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

View more
  25 in total

1.  Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Authors:  Tomoko Date; Takanobu Kato; Junko Kato; Hitoshi Takahashi; Kenichi Morikawa; Daisuke Akazawa; Asako Murayama; Keiko Tanaka-Kaneko; Tetsutaro Sata; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 2.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA.

Authors:  Angela M Lam; Christine Espiritu; Shalini Bansal; Holly M Micolochick Steuer; Veronique Zennou; Michael J Otto; Phillip A Furman
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient.

Authors:  Huang Cao; Wandi Zhu; Qingxia Han; Rongjuan Pei; Xinwen Chen
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

5.  Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.

Authors:  Asako Murayama; Nao Sugiyama; Ryosuke Suzuki; Masaki Moriyama; Noriko Nakamura; Hidenori Mochizuki; Takaji Wakita; Takanobu Kato
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.

Authors:  Robert Smolic; Martina Smolic; John H Andorfer; Catherine H Wu; Robert M Smith; George Y Wu
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

7.  The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase.

Authors:  Vaishnavi Rajagopal; Madhura Gurjar; Mikhail K Levin; Smita S Patel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

8.  The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus.

Authors:  Daniel M Jones; Arvind H Patel; Paul Targett-Adams; John McLauchlan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.

Authors:  Guaniri Mateu; Ruben O Donis; Takaji Wakita; Jens Bukh; Arash Grakoui
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

10.  RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells.

Authors:  Asako Murayama; Leiyun Weng; Tomoko Date; Daisuke Akazawa; Xiao Tian; Tetsuro Suzuki; Takanobu Kato; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita; Tetsuya Toyoda
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.